UNSPSC 51342907: Vidarabine sodium phosphate

This classification denotes an antiviral agent with the molecular structure C10H12N5O7P.2NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, ZEC0WCC7UA chemically known as 9-.beta.-d-arabinofuranosyladenine 5'-(dihydrogen phosphate), disodium salt, but more commonly known as vidarabine sodium phosphate, which bears US NIH Compound Identifier 224. European Medicines Agency schedules Vidarabine sodium phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05095MIG.

UNSPSC 51342907 Vidarabine sodium phosphate is a Commodity code that represents a specific antiviral pharmaceutical product; however, recent state and local contract activity tagged under this code does not reflect procurement of vidarabine sodium phosphate itself. Instead, the opportunities posted under the code involve broader pharmaceutical supply and drug-management services—specifically, piggyback warehouse contracts for antibiotic tablets and competitive bidding for naloxone and drug deactivation systems. State and local issuing bodies using this code span state health departments and county public-health agencies, with solicitations structured through cooperative purchasing consortia (MMCAP Infuse) and direct competitive bidding. The work being bought includes pharmaceutical product supply under master agreements with renewal options, as well as specialized pharmaceutical commodities and harm-reduction equipment with defined annual quantities and delivery schedules.

Recent activity appears concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through MMCAP Infuse on August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392) for doxycycline and ciprofloxacin products totaling $2,999,999.11 over 12 months with two renewal options; this was an Invitation for Bid process with a response date of September 11, 2026. Seminole County, Florida released an IFB (Number IFB60459723LAS) on June 30, 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The code shows limited recent activity, and the mismatch between the nominal commodity (vidarabine sodium phosphate) and the actual procurements posted (other antibiotics, naloxone, and drug-deactivation systems) suggests either data-tagging inconsistency or that vidarabine-specific demand from state and local buyers is not currently driving solicitation volume.